In September 2019, the online pharmacy company known as Valisure filed a citizen petition with the U.S. Food and Drug Administration (FDA) stating that some batches of Zantac, a popular heartburn medication composed of ranitidine, contained dangerous levels of a probable human carcinogen called N-nitrosodimethylamine (NDMA). In the months after the FDA issued its first public warning, the agency continued to issue dozens of warnings and voluntary recalls for both brand and generic name versions of ranitidine.
Because Zantac is easily available over-the-counter as well as by prescription, millions of people may be affected by these dangerous defects. If you or your loved ones have been diagnosed with cancer as a result of taking Zantac, our committed defective drug lawyers at Schlesinger Law Offices, P.A. can help you through the process of filing a lawsuit.
Learn more about how we can help with your Fisher-Price recall case during a free initial evaluation. Give our award winning attorneys a call at (954) 467-8800, or contact us online to schedule a time to speak with a member of our team.
Affected Batches of Zantac and Ranitidine
According to some calculations, Zantac is prescribed for heartburn and indigestion up to 15 million times per year – and millions of people also purchase this medication from drugstore counters across the country. To date, multiple batches of ranitidine medications have been pulled from drugstore and pharmacy shelves in a wave of voluntary recalls.
As of February 24, 2020, Here Are the Companies That Have Recalled Ranitidine Medications, Including Brand Name Zantac:
- Dr. Reddy’s
- American Health Packaging
- Golden State Medical Supply, Inc.
- Novitium Pharma
- Amneal Pharmaceuticals, LLC
- Glenmark Pharmaceuticals Inc.
- Lannett Company, Inc.
- Precision Dose Inc.
- Aurobindo Pharma USA, Inc.
- Appco Pharma LLC
For a full and up-to-date list of affected lots and batches, visit the FDA website here.
How Serious Is the Cancer Risk Posed by NDMA?
At first, the FDA claimed that the levels of NDMA posed minimal risks to patient health, saying that they rarely rose above the recommended 96 nanograms of NDMA per day: “Similar to the levels a consumer would expect… when eating common foods like grilled and smoked meats.” However, later studies have sounded the alarm about the heightened NDMA levels in defective batches of Zantac.
Most recently, testing at an independent lab owned by Emery Pharma showed that heat and time may be the primary causes of Zantac contamination. According to the Emery Pharma researchers, their study suggests that exposing Zantac even to common daytime temperatures could trigger a dangerous rise in NDMA levels. The contamination levels also increase over time, surpassing the 96 nanogram-limit within at least 5 days of exposure to intense heat.
Filing a Claim for Zantac-Related Injuries
When pharmaceutical companies fail to accurately test medications and ensure they are safe for regular use, they may ultimately be held liable for any resulting injuries. While consuming Zantac for a short period may not cause cancer, long-term use does come with unacceptable cancer risks.
Defective drug cases are often complicated to navigate, however, as major pharmaceutical companies like Sanofi are well-equipped to fight back against consumer injury claims. At Schlesinger Law Offices, P.A., our seasoned product liability attorneys in Fort Lauderdale will help you explore your options after a cancer diagnosis – and stand by your side throughout the legal process.
I can't thank the team of lawyers from Schlesinger Law Firm for their high quality of professionalism and persistence in pursuing my lawsuit. They always made me feel part of their family.